
    
      This is a randomized, double-blind, placebo-controlled study designed to evaluate the
      efficacy and safety of 2 fixed doses of lurasidone (20 mg/day and 60 mg/day) for 6 weeks
      compared with placebo in pediatric and adolescent subjects with irritability associated with
      autistic disorder who reside in the community setting.
    
  